Component

Urinary chromium excretion

Urinary chromium excretion. Species, exposure and limitations are retained in each linked claim.

3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

Read recorded mechanisms Open recursive mind map

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Insulin-associated urinary chromium loss increased alongside a low-molecular-weight fraction interpreted as probable chromodulin in the rat study.

    Insulin → Urinary chromium excretion source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/chromium-research/11472024.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8760ddbb2dd372b94d71880c6c95441fb876ed2196b4f111988aae1244b3daba", "start_char": 0, "end_char": 1224, "text_sha256": "8760ddbb2dd372b94d71880c6c95441fb876ed2196b4f111988aae1244b3daba"}
    experimental_model
    In-vivo chromium tracing with insulin stimulation
    exposure
    Administered chromium with transferrin transport and insulin comparisons
    limitations
    Rat tracer findings do not establish a required human insulin-signaling cofactor. Identification of urinary chromodulin was tentative in the indexed abstract.
    nutrient_topic
    Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
    organism
    Rat
    plain_language
    The experiment links insulin exposure to chromium loss, but the identity and physiological role of the urinary complex need qualification.
    primary_references
    [chromium-p11472024] The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin. (2001). https://pubmed.ncbi.nlm.nih.gov/11472024/ DOI: 10.1007/s007750100238
    tissue_or_cell_type
    Blood, tissues and urine

    Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 211–222

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · In-vivo chromium tracing with insulin stimulation · source_derived_draft · unverified_draft

    ### chromium-insulin-urinary-chromium Insulin-associated urinary chromium loss increased alongside a low-molecular-weight fraction interpreted as probable chromodulin in the rat study. Condition category: normal nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: The experiment links insulin exposure to chromium loss, but the identity and physiological role of the urinary complex need qualification. organism: Rat tissue_or_cell_type: Blood, tissues and urine experimental_model: In-vivo chromium tracing with insulin stimulation limitations: Rat tracer findings do not establish a required human insulin-signaling cofactor. Identification of urinary chromodulin was tentative in the indexed abstract. exposure: Administered chromium with transferrin transport and insulin comparisons evidence_span: {"source_cache": "artifacts/chromium-research/11472024.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8760ddbb2dd372b94d71880c6c95441fb876ed2196b4f111988aae1244b3daba", "start_char": 0, "end_char": 1224, "text_sha256": "8760ddbb2dd372b94d71880c6c95441fb876ed2196b4f111988aae1244b3daba"} [chromium-p11472024] The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin. (2001). https://pubmed.ncbi.nlm.nih.gov/11472024/ DOI: 10.1007/s007750100238
    Complete structured claim and evidence

  2. Rapid urinary loss accounted for much newly absorbed chromium picolinate; in the human comparison, seven-day retention was similarly low for picolinate and phenylalaninate.

    Chromium(III) picolinate / CrPic → Urinary chromium excretion source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/chromium-research/22814636.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "392f4199c0cee925fff5f02ee9ce7d12047f9be5d278a55d09da0a3bb707c4b6", "start_char": 0, "end_char": 1673, "text_sha256": "392f4199c0cee925fff5f02ee9ce7d12047f9be5d278a55d09da0a3bb707c4b6"}
    experimental_model
    Radiolabeled-compound whole-body counting in rats and a human volunteer
    exposure
    Oral 51Cr-labeled supplement complexes; human intraindividual comparison of picolinate and phenylalaninate
    limitations
    Human component was a volunteer comparison, not a large population trial. Apparent absorption, absorbed amount before early urinary loss and seven-day retention are different quantities.
    nutrient_topic
    Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
    organism
    Rat and human; species-specific results retained
    plain_language
    A compound can enter the body more readily yet leave quickly, without increasing retained chromium.
    primary_references
    [chromium-p22814636] Bioavailability of chromium(III)-supplements in rats and humans. (2012). https://pubmed.ncbi.nlm.nih.gov/22814636/ DOI: 10.1007/s10534-012-9571-5
    tissue_or_cell_type
    Intestinal uptake, urine and whole-body retention

    Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 120–131

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Radiolabeled-compound whole-body counting in rats and a human volunteer · source_derived_draft · unverified_draft

    ### chromium-picolinate-absorption-retention Rapid urinary loss accounted for much newly absorbed chromium picolinate; in the human comparison, seven-day retention was similarly low for picolinate and phenylalaninate. Condition category: normal nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: A compound can enter the body more readily yet leave quickly, without increasing retained chromium. organism: Rat and human; species-specific results retained tissue_or_cell_type: Intestinal uptake, urine and whole-body retention experimental_model: Radiolabeled-compound whole-body counting in rats and a human volunteer limitations: Human component was a volunteer comparison, not a large population trial. Apparent absorption, absorbed amount before early urinary loss and seven-day retention are different quantities. exposure: Oral 51Cr-labeled supplement complexes; human intraindividual comparison of picolinate and phenylalaninate evidence_span: {"source_cache": "artifacts/chromium-research/22814636.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "392f4199c0cee925fff5f02ee9ce7d12047f9be5d278a55d09da0a3bb707c4b6", "start_char": 0, "end_char": 1673, "text_sha256": "392f4199c0cee925fff5f02ee9ce7d12047f9be5d278a55d09da0a3bb707c4b6"} [chromium-p22814636] Bioavailability of chromium(III)-supplements in rats and humans. (2012). https://pubmed.ncbi.nlm.nih.gov/22814636/ DOI: 10.1007/s10534-012-9571-5
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. The neonatal study found no relation of measured plasma or urinary chromium to its assessed laboratory parameters or morbidity.

    Circulating chromium concentration → Neonatal morbidity measurements source_derived_draftungraded
    Experimental context and source evidence
    availability_state
    biomarker_context Imported condition classification; unverified.
    evidence_span
    {"source_cache": "artifacts/chromium-research/39898458.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1776af33c0e684df33140b02e64d6cb2b4fa727cc167e6b17662e0f4c74275c7", "start_char": 0, "end_char": 1530, "text_sha256": "1776af33c0e684df33140b02e64d6cb2b4fa727cc167e6b17662e0f4c74275c7"}
    experimental_model
    Prospective observational study; 97 very-low-birthweight infants
    exposure
    Parenteral nutrition without added chromium from day 1; plasma days 15/30 and urine day 30
    limitations
    No added chromium does not mean zero exposure because components can contain chromium. Observational biomarker findings do not establish adequacy thresholds or universal neonatal dosing guidance.
    nutrient_topic
    Chromium research collection; topical membership is not evidence of a direct dietary effect. · Chromium
    organism
    Human premature infants
    plain_language
    The measured chromium differences were not linked to the reported clinical outcomes.
    primary_references
    [chromium-p39898458] Chromium-free parenteral nutrition and its effects on chromium levels in very low birth weight infants. (2025). https://pubmed.ncbi.nlm.nih.gov/39898458/ DOI: 10.20960/nh.05609
    tissue_or_cell_type
    Plasma and urine during neonatal nutrition
    trigger_kind
    biomarker_context Imported condition classification; unverified.

    Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17) · lines 939–950

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Prospective observational study; 97 very-low-birthweight infants · source_derived_draft · unverified_draft

    ### chromium-neonatal-marker-outcome-null The neonatal study found no relation of measured plasma or urinary chromium to its assessed laboratory parameters or morbidity. Condition category: biomarker_context nutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect. plain_language: The measured chromium differences were not linked to the reported clinical outcomes. organism: Human premature infants tissue_or_cell_type: Plasma and urine during neonatal nutrition experimental_model: Prospective observational study; 97 very-low-birthweight infants limitations: No added chromium does not mean zero exposure because components can contain chromium. Observational biomarker findings do not establish adequacy thresholds or universal neonatal dosing guidance. exposure: Parenteral nutrition without added chromium from day 1; plasma days 15/30 and urine day 30 evidence_span: {"source_cache": "artifacts/chromium-research/39898458.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1776af33c0e684df33140b02e64d6cb2b4fa727cc167e6b17662e0f4c74275c7", "start_char": 0, "end_char": 1530, "text_sha256": "1776af33c0e684df33140b02e64d6cb2b4fa727cc167e6b17662e0f4c74275c7"} [chromium-p39898458] Chromium-free parenteral nutrition and its effects on chromium levels in very low birth weight infants. (2025). https://pubmed.ncbi.nlm.nih.gov/39898458/ DOI: 10.20960/nh.05609
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards